EN
IT
Search
About us
The Company
Where we are
Neupharma for social
Areas of Interest
Cystic Fibrosis
Hypovitaminosis D
Products
Inhaled Antibiotic Therapy
Foods for Medical Purposes and Supplements
PARI Medical Device Service
Medical devices for nasal washing
Contacts
News
News
Focus on
Espandi barra di navigazione
Menu
Search
About us
The Company
Where we are
Neupharma for social
Areas of Interest
Cystic Fibrosis
Hypovitaminosis D
Products
Inhaled Antibiotic Therapy
Foods for Medical Purposes and Supplements
PARI Medical Device Service
Medical devices for nasal washing
Contacts
News
News
Focus on
Language
English
Italiano
Home
News
News
Thanks to Alba Onlus Cystic Fibrosis Association!
09 March 2023
Neupharma supports Mr. Pietro Armani's Association for patients with cystic fibrosis from Belarus, Ukraine and Kazakhstan
Continue
Neupharma takes part in solidarity initiative in favor of ANT
24 October 2022
A vehicle is donated in favor Of ANT and it will be used for home assistance to sick people and for social transport
Continue
Together for Ukraine
07 April 2022
Neupharma took part to the charity collection of pharmaceutical products in order to help Cystic Fibrosis patients in war-affected areas
Continue
Happy Birthday Neupharma!
29 March 2022
Neupharma celebrates its 10th corporate anniversary with a new cover image
Continue
DKD Approval for Rare Disease
17 March 2022
DKD obtained approval as Food for Special Medical Purposes for Osteogenesis Imperfecta, Ehlers-Danlos Syndrome, Deficiency Rickets
Continue
Merry Christmas 2021!!
21 December 2021
Neupharma Team wishes our website users merry Christmas and a happy new year 2022
Continue
Neupharma honoured by Le Fonti Awards 2021
26 November 2021
Neupharma and Davide Fiumi (CEO) honoured for "Corporate Social Responsibility in Healthcare"
Continue
Neupharma and #MiFidoDiTe (“I trust you”)
13 May 2021
Neupharma Srl will sponsor a summer leg of the “MiFidoDiTe” charity project during the Italian Open Water Tour 2021
Continue
Inhaled teicoplanin completed phase 1 clinical trial in cystic fibrosis
18 March 2021
Neupharma announces the positive conclusion of the phase 1 study, conducted at the “Azienda Ospedaliera Universitaria Integrata” of Verona, with the formulation of inhaled teicoplanin in CF patients.
Continue
1
(current)
2
3
»
Category list